Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v2.4.0.6
Consolidated Financial Statement Detail (Tables)
12 Months Ended
Dec. 31, 2012
Consolidated Financial Statement Detail [Abstract]  
Receivables
Receivables consisted of the following at December 31, 2012 and 2011 (in thousands):

   
December 31,
 
   
2012
   
2011
 
Trade receivables, net
  $ 7,477     $ 11,820  
Other receivables
    772       512  
Total
  $ 8,249     $ 12,332  
Property and equipment
Property and Equipment

Property and equipment consisted of the following at December 31, 2012 and 2011 (in thousands):

   
December 31,
 
   
2012
   
2011
 
Furniture and equipment
  $ 25,734     $ 33,483  
Buildings, leasehold and building improvements
    21,656       21,490  
Construction-in-progress
    1,832       973  
Land
    310       310  
      49,532       56,256  
Less:  Accumulated depreciation and amortization
    (41,389 )     (43,547 )
Property and equipment, net
  $ 8,143     $ 12,709  
Accrued liabilities
Accrued liabilities consisted of the following at December 31, 2012 and 2011 (in thousands):

   
December 31,
 
   
2012
   
2011
 
Accrued management incentive compensation
  $ 3,802     $ 4,096  
Accrued payroll and other benefits
    2,461       3,007  
Accrued severance payments
    490       1,207  
Accrued clinical trial costs
    4,702       140  
Other
    1,535       1,562  
Total
  $ 12,990     $ 10,012